KSC · 207940.KS
Samsung Biologics Co.,Ltd.
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
Loading market information…
KOE · 078160.KQ · KRW
Stock price, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
MEDIPOST Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 72.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
MEDIPOST Co., Ltd.’s next earnings report is currently expected on Nov 12, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow MEDIPOST Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Medipost Co., Ltd. is a biotechnology firm dedicated to the creation and manufacturing of stem cell-based products. Its diverse operations are categorized into several divisions: the Cord Blood Bank, which specializes in the collection and storage of newborn umbilical cord stem cells; Stem Cell Therapy, focused on producing allogeneic stem cell pharmaceuticals; Health Functional Food, offering various vitamins and nutritional supplements; and the Import and Distribution of Natural Cosmetics division, responsible for the sales and marketing of natural cosmetic products sourced from Pevonia Inc. Additionally, the company provides comprehensive Healthcare Services, encompassing bizcare, insu-care, affiliate programs, telehealth, and medical devices, accessible via web, mobile, and call centers. Established on June 26, 2000, by Yoon-Sun Yang and Won-Il Oh, Medipost Co., Ltd. is headquartered in Seongnam, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩1,487,000+₩121,000 (+8.86%)
Samsung Biologics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.16% below the high.
₩191,600+₩2,300 (+1.22%)
Celltrion, Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.85% below the high.
₩21,800-₩400 (-1.8%)
NatureCell Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.0% below the high.
₩13,920-₩380 (-2.66%)
Kolon TissueGene, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.66% below the high.
₩6,750-₩10 (-0.15%)
Chabiotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.82% below the high.
₩9,400-₩400 (-4.08%)
Pharmicell Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 55.56% below the high.
₩9,140+₩20 (+0.22%)
GC Corp.’s quoted price sits in the lower half of its reported 52-week range, 49.25% below the high.
₩13,360-₩720 (-5.11%)
Anterogen.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 78.38% below the high.
